David A. Siegel Eton Pharmaceuticals, Inc. Transaction History

Two Sigma Advisers, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$3.48 - $5.03 $23,664 - $34,204	6,800 Added 62.39%	17,700 $66,000
Q4 2023 Feb 14, 2024	BUY	$3.45 - $4.66 $37,605 - $50,794	10,900 New	10,900 $47,000
Q2 2021 Aug 16, 2021	SELL	$5.71 - $8.85 $210,699 - $326,565	-36,900 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.93 - $10.07 $160,083 - $232,617	23,100 Added 167.39%	36,900 $270,000
Q4 2020 Feb 16, 2021	BUY	$6.65 - $8.83 $91,770 - $121,854	13,800 New	13,800 $112,000

9.44M

261K

500

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $264M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.